-
1
-
-
68949172254
-
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
-
10.1016/S0140-6736(09)60742-X published online July 13, 2009.
-
Tiihonen J., Lönnqvist J., Wahlbeck K., et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet (2009) 10.1016/S0140-6736(09)60742-X published online July 13, 2009.
-
(2009)
Lancet
-
-
Tiihonen, J.1
Lönnqvist, J.2
Wahlbeck, K.3
-
2
-
-
0032751075
-
Antipsychotic-induced weight gain: a comprehensive research synthesis
-
Allison D.B., Mentore J.L., Heo M., et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 156 (1999) 1686-1696
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1686-1696
-
-
Allison, D.B.1
Mentore, J.L.2
Heo, M.3
-
3
-
-
0036213607
-
Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia
-
Sernyak M.J., Leslie D.L., Alarcon R.D., Losonczy M.F., and Rosenheck R. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 159 (2002) 561-566
-
(2002)
Am J Psychiatry
, vol.159
, pp. 561-566
-
-
Sernyak, M.J.1
Leslie, D.L.2
Alarcon, R.D.3
Losonczy, M.F.4
Rosenheck, R.5
-
4
-
-
0036774640
-
Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database
-
Gianfrancesco F.D., Grogg A.L., Mahmoud R.A., Wang R.H., and Nasrallah H.A. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 63 (2002) 920-930
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 920-930
-
-
Gianfrancesco, F.D.1
Grogg, A.L.2
Mahmoud, R.A.3
Wang, R.H.4
Nasrallah, H.A.5
-
5
-
-
43049092201
-
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1
-
Meyer J.M., Davis V.G., Goff D.C., et al. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophr Res 101 (2008) 273-286
-
(2008)
Schizophr Res
, vol.101
, pp. 273-286
-
-
Meyer, J.M.1
Davis, V.G.2
Goff, D.C.3
-
6
-
-
47249104183
-
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1
-
Meyer J.M., Davis V.G., McEvoy J.P., et al. Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophr Res 103 (2008) 104-109
-
(2008)
Schizophr Res
, vol.103
, pp. 104-109
-
-
Meyer, J.M.1
Davis, V.G.2
McEvoy, J.P.3
-
7
-
-
54849381700
-
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study
-
Daumit G.L., Goff D.C., Meyer J.M., et al. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res 105 (2008) 175-187
-
(2008)
Schizophr Res
, vol.105
, pp. 175-187
-
-
Daumit, G.L.1
Goff, D.C.2
Meyer, J.M.3
-
8
-
-
34248562315
-
Antipsychotic medications: metabolic and cardiovascular risk
-
Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68 suppl 4 (2007) 8-13
-
(2007)
J Clin Psychiatry
, vol.68
, Issue.SUPPL. 4
, pp. 8-13
-
-
Newcomer, J.W.1
-
9
-
-
67349119802
-
UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study)
-
Barnett A.H., Millar H.L., Loze J.Y., L'Italien G.J., van Baardewijk M., and Knapp M. UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study). Eur Arch Psychiatry Clin Neurosci 259 (2009) 239-247
-
(2009)
Eur Arch Psychiatry Clin Neurosci
, vol.259
, pp. 239-247
-
-
Barnett, A.H.1
Millar, H.L.2
Loze, J.Y.3
L'Italien, G.J.4
van Baardewijk, M.5
Knapp, M.6
-
10
-
-
33750061308
-
Clozapine utilization and outcomes by race in a public mental health system: 1994-2000
-
Kelly D.L., Dixon L.B., Kreyenbuhl J.A., et al. Clozapine utilization and outcomes by race in a public mental health system: 1994-2000. J Clin Psychiatry 67 (2006) 1404-1411
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 1404-1411
-
-
Kelly, D.L.1
Dixon, L.B.2
Kreyenbuhl, J.A.3
-
11
-
-
33748768220
-
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia
-
Lewis S.W., Barnes T.R., Davies L., et al. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull 32 (2006) 715-723
-
(2006)
Schizophr Bull
, vol.32
, pp. 715-723
-
-
Lewis, S.W.1
Barnes, T.R.2
Davies, L.3
|